1	GENEVA	geneva	NNP	_	5	nn	_
2	&	&	CC	_	1	cc	_
3	ARCHAMPS	archamps	NNP	_	1	conj	_
4	,	,	,	_	5	punct	_
5	France	france	NNP	_	23	nsubj	23:A0=PAG
6	--	--	:	_	5	punct	_
7	(	(	-LRB-	_	5	punct	_
8	BUSINESS	business	NNP	p2=NN	9	nn	_
9	WIRE	wire	NNP	_	5	appos	_
10	)	)	-RRB-	_	5	punct	_
11	--	--	:	_	5	punct	_
12	Genkyotex	genkyotex	NNP	_	5	appos	_
13	,	,	,	_	12	punct	_
14	the	the	DT	_	16	det	_
15	leading	lead	VBG	p2=JJ|pb=lead.01	16	amod	_
16	developer	developer	NN	_	12	appos	15:A0=PAG
17	of	of	IN	_	16	prep	_
18	selective	selective	JJ	_	21	amod	_
19	NOX	nox	NNP	p2=NN	20	nn	_
20	enzyme	enzyme	NNP	p2=NN	21	nn	_
21	inhibitors	inhibitor	NNS	p2=NNP	17	pobj	_
22	,	,	,	_	23	punct	_
23	announced	announce	VBD	pb=announce.01	0	root	_
24	today	today	NN	_	23	npadvmod	23:AM-TMP
25	the	the	DT	_	26	det	_
26	appointment	appointment	NN	_	23	dobj	23:A1=PPT
27	of	of	IN	_	26	prep	_
28	Dr.	dr.	NNP	_	30	nn	_
29	Jeanette	jeanette	NNP	_	30	nn	_
30	Wood	wood	NNP	_	27	pobj	_
31	as	as	IN	_	26	prep	_
32	Chief	chief	NNP	_	34	nn	_
33	Scientific	scientific	NNP	_	34	nn	_
34	Officer	officer	NNP	_	31	pobj	_
35	and	and	CC	_	34	cc	_
36	Dr.	dr.	NNP	_	38	nn	_
37	Joseph	joseph	NNP	_	38	nn	_
38	McCracken	mccracken	NNP	_	34	conj	_
39	to	to	IN	_	26	prep	_
40	the	the	DT	_	41	det	_
41	Board	board	NNP	_	39	pobj	_
42	of	of	IN	_	41	prep	_
43	Directors	director	NNPS	p2=NNS	42	pobj	_
44	.	.	.	_	23	punct	_

1	Dr.	dr.	NNP	_	2	nn	_
2	Wood	wood	NNP	_	3	nsubj	3:A0=PAG
3	joins	join	VBZ	pb=join.01	0	root	_
4	Genkyotex	genkyotex	NNP	_	3	dobj	3:A1=PPT
5	with	with	IN	_	3	prep	3:A2=MNR
6	more	more	JJR	_	8	amod	_
7	than	than	IN	_	8	quantmod	_
8	30	0	CD	_	9	num	_
9	years	year	NNS	_	11	nn	_
10	research	research	NN	p2=VBP	11	nn	_
11	experience	experience	NN	_	5	pobj	_
12	in	in	IN	_	11	prep	_
13	the	the	DT	_	15	det	_
14	pharmaceutical	pharmaceutical	JJ	p2=NN	15	nn	_
15	industry	industry	NN	_	12	pobj	_
16	,	,	,	_	3	punct	_
17	most	most	RBS	_	18	advmod	_
18	recently	recently	RB	_	19	advmod	_
19	at	at	IN	_	3	prep	_
20	AstraZeneca	astrazeneca	NNP	_	19	pobj	_
21	.	.	.	_	3	punct	_

1	In	in	IN	_	16	prep	16:AM-LOC
2	her	her	PRP$	_	3	poss	_
3	role	role	NN	_	1	pobj	_
4	as	as	IN	_	3	prep	_
5	Vice	vice	NNP	_	6	nn	_
6	President	president	NNP	_	4	pobj	_
7	and	and	CC	_	6	cc	_
8	Head	head	NNP	_	6	conj	_
9	of	of	IN	_	6	prep	_
10	iScience	iscience	NNP	p2=NN	9	pobj	_
11	,	,	,	_	6	punct	_
12	Oncology	oncology	NNP	_	13	nn	_
13	iMed	imed	NNP	p2=VBD	6	appos	_
14	,	,	,	_	16	punct	_
15	she	she	PRP	p2=NN	16	nsubj	34:A0=PAG;16:A1=PPT
16	was	be	VBD	pb=be.01	0	root	_
17	responsible	responsible	JJ	_	16	acomp	16:A2=PRD
18	for	for	IN	_	17	prep	_
19	the	the	DT	_	23	det	_
20	oncology	oncology	JJ	p2=NN	23	amod	_
21	early	early	JJ	_	22	amod	_
22	discovery	discovery	NN	_	23	nn	_
23	portfolio	portfolio	NN	_	18	pobj	26:A1=PPT
24	,	,	,	_	23	punct	_
25	which	which	WDT	_	26	nsubj	26:R-A1
26	consisted	consist	VBD	pb=consist.01	23	rcmod	_
27	mostly	mostly	RB	_	26	advmod	26:AM-ADV
28	of	of	IN	_	26	prep	26:A2=VSP
29	small	small	JJ	_	31	amod	_
30	molecule	molecule	NN	p2=JJ	31	nn	_
31	candidates	candidate	NNS	_	28	pobj	_
32	,	,	,	_	23	punct	_
33	and	and	CC	_	16	cc	_
34	leading	lead	VBG	pb=lead.01	16	conj	_
35	the	the	DT	_	36	det	_
36	biology	biology	NN	_	41	nn	_
37	,	,	,	_	36	punct	_
38	chemistry	chemistry	NN	_	36	conj	_
39	and	and	CC	_	38	cc	_
40	DMPK	dmpk	NNP	p2=NN	38	conj	_
41	functions	function	NNS	_	34	dobj	44:A0;34:A1=PPT
42	,	,	,	_	41	punct	_
43	which	which	WDT	_	44	nsubj	44:R-A0
44	support	support	VBP	p2=NN|pb=support.01	41	rcmod	_
45	both	both	CC	p2=DT	50	predet	_
46	the	the	DT	_	50	det	_
47	research	research	NN	_	50	nn	_
48	and	and	CC	_	47	cc	_
49	development	development	NN	_	47	conj	_
50	portfolios	portfolio	NNS	_	44	dobj	44:A1
51	.	.	.	_	16	punct	_

1	 Before	 before	NNP	p2=IN	2	nsubj	2:A0=PAG
2	joining	join	VBG	pb=join.01	7	advcl	7:AM-ADV
3	AstraZeneca	astrazeneca	NNP	_	2	dobj	2:A1=PPT
4	,	,	,	_	7	punct	_
5	Dr.	dr.	NNP	_	6	nn	_
6	Wood	wood	NNP	_	7	nsubj	7:A1=PPT
7	was	be	VBD	pb=be.01	0	root	_
8	Head	head	NNP	_	7	attr	7:A2=PRD
9	of	of	IN	_	8	prep	_
10	Biology	biology	NNP	p2=NN	9	pobj	_
11	at	at	IN	_	7	prep	7:AM-LOC
12	oncology	oncology	NN	p2=PRP$	13	nn	_
13	company	company	NN	_	16	nn	_
14	S*BIO	s*bio	NNP	_	16	nn	_
15	Pte	pte	NNP	_	16	nn	_
16	Ltd	ltd	NNP	_	11	pobj	_
17	in	in	IN	_	16	prep	_
18	Singapore	singapore	NNP	_	17	pobj	_
19	.	.	.	_	7	punct	_

1	For	for	IN	_	9	prep	9:AM-TMP
2	more	more	JJR	_	4	amod	_
3	than	than	IN	_	4	quantmod	_
4	11	0	CD	_	5	num	_
5	years	year	NNS	_	1	pobj	_
6	,	,	,	_	9	punct	_
7	Dr.	dr.	NNP	_	8	nn	_
8	Wood	wood	NNP	_	9	nsubj	9:A0=PAG
9	worked	work	VBD	pb=work.01	0	root	_
10	in	in	IN	_	9	prep	9:AM-LOC
11	the	the	DT	_	13	det	_
12	oncology	oncology	NN	p2=JJ	13	nn	_
13	unit	unit	NN	_	10	pobj	_
14	of	of	IN	_	13	prep	_
15	Novartis	novartis	NNP	p2=NNPS	16	nsubj	_
16	developing	develop	VBG	pb=develop.01	14	pcomp	_
17	expertise	expertise	NN	_	16	dobj	16:A1=LOC
18	and	and	CC	_	13	cc	_
19	a	a	DT	_	20	det	_
20	portfolio	portfolio	NN	_	13	conj	21:A1=PPT
21	based	base	VBN	pb=base.02	20	partmod	_
22	on	on	IN	_	21	prep	21:A2=DIR
23	angiogenesis	angiogenesis	NN	p2=NNS	22	pobj	_
24	.	.	.	_	9	punct	_

1	Her	her	PRP$	_	3	poss	_
2	industry	industry	NN	_	3	nn	_
3	career	career	NN	_	4	nsubj	4:A1=PPT
4	started	start	VBD	pb=start.01	0	root	_
5	in	in	IN	_	4	prep	4:AM-LOC
6	the	the	DT	_	8	det	_
7	cardiovascular	cardiovascular	JJ	_	8	amod	_
8	group	group	NN	_	5	pobj	_
9	at	at	IN	_	8	prep	_
10	Ciba	ciba	NNP	_	12	hmod	_
11	-	-	HYPH	_	12	hyph	_
12	Geigy	geigy	NNP	_	9	pobj	_
13	,	,	,	_	12	punct	_
14	where	where	WRB	_	20	advmod	_
15	as	as	IN	_	20	mark	_
16	Hypertension	hypertension	NNP	p2=NN	18	nn	_
17	Group	group	NNP	_	18	nn	_
18	Leader	leader	NNP	_	15	pobj	_
19	she	she	PRP	_	20	nsubj	20:A0=PAG
20	led	lead	VBD	pb=lead.02	4	advcl	_
21	the	the	DT	_	22	det	_
22	team	team	NN	_	20	dobj	24:A0=PAG;20:A1=PPT
23	that	that	WDT	_	24	nsubj	24:R-A0
24	played	play	VBD	pb=play.02	22	rcmod	_
25	a	a	DT	_	27	det	_
26	major	major	JJ	_	27	amod	_
27	role	role	NN	_	24	dobj	24:A1=PPT
28	in	in	IN	_	24	prep	24:AM-LOC
29	the	the	DT	_	30	det	_
30	discovery	discovery	NN	_	28	pobj	_
31	and	and	CC	_	30	cc	_
32	development	development	NN	_	30	conj	_
33	of	of	IN	_	30	prep	_
34	the	the	DT	_	39	det	_
35	angiotensin	angiotensin	NN	p2=JJ	39	amod	_
36	II	ii	NNP	p2=CD	39	nn	_
37	receptor	receptor	NN	_	38	nn	_
38	antagonist	antagonist	NN	p2=JJ	39	nn	_
39	valsartan	valsartan	NN	p2=NNP	33	pobj	_
40	(	(	-LRB-	_	41	punct	_
41	DIOVAN	diovan	NNP	_	39	appos	_
42	)	)	-RRB-	_	41	punct	_
43	and	and	CC	_	39	cc	_
44	the	the	DT	_	46	det	_
45	renin	renin	NN	p2=JJ	46	nn	_
46	inhibitor	inhibitor	NN	p2=VBP	47	nn	_
47	aliskiren 	aliskiren 	NNP	p2=''	39	conj	_
48	(	(	-LRB-	_	49	punct	_
49	TEKTURNA	tekturna	NNP	_	47	appos	_
50	)	)	-RRB-	_	49	punct	_
51	.	.	.	_	4	punct	_

1	Dr.	dr.	NNP	_	2	nn	_
2	Wood	wood	NNP	_	3	nsubj	3:A0=PAG
3	earned	earn	VBD	pb=earn.01	0	root	_
4	her	her	PRP$	p2=PRP	5	poss	_
5	PhD	phd	NN	_	3	dobj	3:A1=PPT
6	in	in	IN	_	3	prep	3:AM-LOC
7	pharmacology	pharmacology	NN	_	6	pobj	_
8	from	from	IN	_	3	prep	3:A3=DIR
9	the	the	DT	_	10	det	_
10	University	university	NNP	_	8	pobj	_
11	of	of	IN	_	10	prep	_
12	Otago	otago	NNP	_	11	pobj	_
13	(	(	-LRB-	_	10	punct	_
14	Dunedin	dunedin	NNP	_	10	appos	_
15	,	,	,	_	14	punct	_
16	New	new	NNP	_	17	nn	_
17	Zealand	zealand	NNP	_	14	appos	_
18	)	)	-RRB-	_	10	punct	_
19	.	.	.	_	3	punct	_

1	Dr.	dr.	NNP	_	3	nn	_
2	Joe	joe	NNP	_	3	nn	_
3	McCracken	mccracken	NNP	_	4	nsubj	4:A0=PAG
4	has	have	VBZ	pb=have.03	0	root	_
5	more	more	JJR	p2=RBR	7	amod	_
6	than	than	IN	_	7	quantmod	_
7	25	0	CD	_	8	num	_
8	years	year	NNS	_	4	dobj	4:A1=PPT
9	of	of	IN	_	8	prep	_
10	experience	experience	NN	_	9	pobj	_
11	in	in	IN	_	10	prep	_
12	technical	technical	JJ	_	19	amod	_
13	,	,	,	_	19	punct	_
14	business	business	NN	_	15	nn	_
15	development	development	NN	_	19	nn	_
16	and	and	CC	_	15	cc	_
17	market	market	NN	_	18	nn	_
18	development	development	NN	_	15	conj	_
19	roles	role	NNS	_	11	pobj	_
20	with	with	IN	_	19	prep	_
21	biotechnology	biotechnology	NN	_	24	nn	_
22	and	and	CC	_	21	cc	_
23	pharmaceutical	pharmaceutical	NN	p2=JJ	21	conj	_
24	companies	company	NNS	_	20	pobj	_
25	.	.	.	_	4	punct	_

1	Most	most	RBS	p2=JJS	2	advmod	_
2	recently	recently	RB	_	4	advmod	4:AM-TMP
3	he	he	PRP	_	4	nsubj	4:A1=PPT
4	was	be	VBD	pb=be.01	0	root	_
5	Global	global	NNP	p2=JJ	6	nn	_
6	Head	head	NNP	_	4	attr	4:A2=PRD
7	for	for	IN	_	4	prep	_
8	Business	business	NNP	_	9	nn	_
9	Development	development	NNP	_	7	pobj	_
10	&	&	CC	_	9	cc	_
11	Licensing	licensing	NNP	p2=VBG	9	conj	_
12	at	at	IN	_	4	prep	_
13	Roche	roche	NNP	_	14	nn	_
14	Pharma	pharma	NNP	_	12	pobj	18:AM-LOC
15	,	,	,	_	14	punct	_
16	where	where	WRB	_	18	advmod	18:R-AM-LOC
17	he	he	PRP	_	18	nsubj	18:A1=PPT
18	was	be	VBD	pb=be.01	14	rcmod	_
19	responsible	responsible	JJ	_	18	acomp	18:A2=PRD
20	for	for	IN	_	19	prep	_
21	Roche	roche	NNP	_	22	nn	_
22	Pharma	pharma	NNP	_	25	poss	_
23	's	's	POS	_	22	possessive	_
24	global	global	JJ	_	25	amod	_
25	in-licensing	in-licensing	NN	p2=JJ	20	pobj	_
26	and	and	CC	_	20	cc	_
27	out	out	IN	p2=NN	29	hmod	_
28	-	-	HYPH	_	29	hyph	_
29	licensing	licensing	NN	p2=VBG	30	nn	_
30	activities	activity	NNS	_	4	attr	_
31	.	.	.	_	4	punct	_

1	Prior	prior	RB	_	8	advmod	8:AM-TMP
2	to	to	IN	_	1	prep	_
3	Roche	roche	NNP	_	4	nn	_
4	Pharma	pharma	NNP	_	2	pobj	_
5	,	,	,	_	8	punct	_
6	Dr.	dr.	NNP	_	7	nn	_
7	McCracken	mccracken	NNP	_	8	nsubj	8:A0=PAG
8	held	hold	VBD	pb=hold.01	0	root	_
9	the	the	DT	_	10	det	_
10	position	position	NN	_	8	dobj	8:A1=PPT
11	of	of	IN	_	10	prep	_
12	Vice	vice	NNP	_	13	nn	_
13	President	president	NNP	_	11	pobj	_
14	,	,	,	_	13	punct	_
15	Business	business	NNP	_	16	nn	_
16	Development	development	NNP	_	13	appos	_
17	at	at	IN	_	16	prep	_
18	Genentech	genentech	NNP	_	17	pobj	_
19	for	for	IN	_	8	prep	8:AM-TMP
20	more	more	JJR	_	22	amod	_
21	than	than	IN	_	22	quantmod	_
22	10	0	CD	_	23	num	_
23	years	year	NNS	_	19	pobj	_
24	.	.	.	_	8	punct	_

1	He	he	PRP	_	2	nsubj	2:A1=PPT
2	was	be	VBD	pb=be.01	0	root	_
3	also	also	RB	_	2	advmod	2:AM-ADV
4	at	at	IN	_	2	prep	2:A2=PRD
5	one	#crd#	CD	p2=NN	6	num	_
6	time	time	NN	_	4	pobj	_
7	Director	director	NNP	p2=NN	29	nsubj	29:A0=PAG
8	of	of	IN	_	7	prep	_
9	Business	business	NNP	_	10	nn	_
10	Development	development	NNP	_	8	pobj	_
11	and	and	CC	_	7	cc	_
12	Representative	representative	NNP	_	13	nn	_
13	Director	director	NNP	_	7	conj	_
14	of	of	IN	_	13	prep	_
15	Genentech	genentech	NNP	_	16	nn	_
16	Ltd.	ltd.	NNP	_	14	pobj	_
17	,	,	,	_	16	punct	_
18	Genentech	genentech	NNP	_	22	poss	_
19	's	's	POS	_	18	possessive	_
20	wholly	wholly	RB	_	21	advmod	21:AM-EXT
21	owned	own	VBN	p2=JJ|pb=own.01	22	amod	_
22	subsidiary	subsidiary	NN	_	16	appos	21:A1=PPT
23	in	in	IN	_	22	prep	_
24	Japan	japan	NNP	_	23	pobj	_
25	,	,	,	_	2	punct	_
26	and	and	CC	_	2	cc	_
27	has	have	VBZ	_	29	aux	_
28	also	also	RB	_	29	advmod	29:AM-ADV
29	held	hold	VBN	pb=hold.04	2	conj	_
30	the	the	DT	_	31	det	_
31	positions	position	NNS	_	29	dobj	29:A1=PPT
32	of	of	IN	_	31	prep	_
33	President	president	NNP	_	32	pobj	_
34	of	of	IN	_	33	prep	_
35	Technology	technology	NNP	_	36	nn	_
36	Licensing	licensing	NNP	_	34	pobj	_
37	and	and	CC	_	33	cc	_
38	Alliances	alliances	NNP	p2=NNPS	33	conj	_
39	at	at	IN	_	29	prep	29:AM-LOC
40	Aventis	aventis	NNP	_	39	pobj	_
41	,	,	,	_	29	punct	_
42	and	and	CC	_	29	cc	_
43	Vice	vice	NNP	_	44	nn	_
44	President	president	NNP	_	58	nn	_
45	of	of	IN	_	44	prep	_
46	Worldwide	worldwide	NNP	_	50	nn	_
47	Business	business	NNP	_	50	nn	_
48	and	and	CC	_	47	cc	_
49	Technology	technology	NNP	_	47	conj	_
50	Development	development	NNP	_	45	pobj	_
51	at	at	IN	_	44	prep	_
52	Rhone	rhone	NNP	_	54	hmod	_
53	-	-	HYPH	_	54	hyph	_
54	Poulenc	poulenc	NNP	_	56	nn	_
55	Rorer	rorer	NNP	_	56	nn	_
56	S.A.	s.a.	NNP	_	51	pobj	_
57	Dr.	dr.	NNP	_	58	nn	_
58	McCracken	mccracken	NNP	_	59	nsubj	59:A0=PAG
59	holds	hold	VBZ	pb=hold.04	29	conj	_
60	a	a	DT	_	61	det	_
61	BSc	bsc	NNP	p2=NN	59	dobj	59:A1=PPT
62	in	in	IN	_	59	prep	59:AM-LOC
63	Microbiology	microbiology	NNP	_	62	pobj	_
64	,	,	,	_	63	punct	_
65	a	a	DT	_	66	det	_
66	MSc	msc	NNP	_	63	appos	_
67	in	in	IN	_	66	prep	_
68	Pharmacology	pharmacology	NNP	p2=NN	67	pobj	_
69	and	and	CC	_	66	cc	_
70	a	a	DT	_	71	det	_
71	Doctorate	doctorate	NNP	p2=NN	66	conj	_
72	of	of	IN	_	71	prep	_
73	Veterinary	veterinary	NNP	p2=JJ	74	nn	_
74	Medicine	medicine	NNP	_	72	pobj	_
75	from	from	IN	_	71	prep	_
76	The	the	DT	p2=NNP	79	det	_
77	Ohio	ohio	NNP	_	79	nn	_
78	State	state	NNP	_	79	nn	_
79	University	university	NNP	_	75	pobj	_
80	(	(	-LRB-	_	81	punct	_
81	Columbus	columbus	NNP	_	79	appos	_
82	,	,	,	_	81	punct	_
83	Ohio	ohio	NNP	_	81	appos	_
84	,	,	,	_	83	punct	_
85	USA	usa	NNP	_	83	appos	_
86	)	)	-RRB-	_	81	punct	_
87	.	.	.	_	59	punct	_

1	Genkyotex	genkyotex	NNP	p2=NN	3	nsubj	3:A1=LOC
2	is	be	VBZ	_	3	aux	_
3	developing	develop	VBG	pb=develop.01	0	root	_
4	first	#ord#	RB	_	3	advmod	3:AM-TMP
5	in	in	IN	_	3	prep	3:AM-LOC
6	class	class	NN	_	5	pobj	_
7	,	,	,	_	6	punct	_
8	small	small	JJ	_	10	amod	_
9	molecule	molecule	NN	_	10	nn	_
10	therapeutics	therapeutic	NNS	p2=IN	6	conj	15:A0=PAG
11	that	that	WDT	_	15	nsubj	15:R-A0
12	specifically	specifically	RB	_	15	advmod	15:AM-MNR
13	and	and	CC	_	12	cc	_
14	selectively	selectively	RB	_	15	advmod	15:AM-MNR
15	inhibit	inhibit	VB	p2=VBP|pb=inhibit.01	10	rcmod	_
16	the	the	DT	_	18	det	_
17	NOX	nox	NNP	_	18	nn	_
18	family	family	NN	_	15	dobj	15:A1=PPT
19	of	of	IN	_	18	prep	_
20	enzymes	enzyme	NNS	p2=NNP	19	pobj	_
21	.	.	.	_	3	punct	_

1	Using	use	VBG	pb=use.01	9	advcl	9:AM-ADV
2	a	a	DT	_	5	det	_
3	unique	unique	JJ	_	5	amod	_
4	screening	screening	NN	_	5	nn	_
5	platform	platform	NN	_	1	dobj	1:A1=PPT
6	,	,	,	_	9	punct	_
7	Genkyotex	genkyotex	NNP	_	9	nsubj	1:A0=PAG;9:A0=PAG
8	has	have	VBZ	_	9	aux	_
9	identified	identify	VBN	pb=identify.01	0	root	_
10	novel	novel	NN	p2=JJ	12	nn	_
11	NOX	nox	NNP	p2=NN	12	nn	_
12	inhibitors	inhibitor	NNS	p2=VBZ	9	dobj	9:A1=PPT
13	with	with	IN	_	9	prep	9:AM-MNR
14	the	the	DT	_	15	det	_
15	potential	potential	NN	p2=JJ	13	pobj	_
16	to	to	TO	_	17	aux	_
17	treat	treat	VB	pb=treat.03	15	infmod	_
18	disease	disease	NN	_	19	nn	_
19	areas	area	NNS	_	17	dobj	17:A1=PPT
20	with	with	IN	_	17	prep	17:A2=PPT
21	a	a	DT	_	24	det	_
22	high	high	JJ	_	24	amod	_
23	clinical	clinical	JJ	p2=NN	24	amod	_
24	need	need	NN	p2=JJ	20	pobj	_
25	and	and	CC	_	24	cc	_
26	large	large	JJ	_	28	amod	_
27	market	market	NN	_	28	nn	_
28	potential	potential	NN	_	24	conj	_
29	.	.	.	_	9	punct	_

1	The	the	DT	_	2	det	_
2	company	company	NN	_	5	poss	_
3	's	's	POS	_	2	possessive	_
4	lead	lead	JJ	p2=NN	5	amod	_
5	product	product	NN	_	9	nsubj	24:A0=CAU;9:A1=PPT
6	,	,	,	_	5	punct	_
7	GKT137831	gkt137831	NNP	p2=NN	5	appos	_
8	,	,	,	_	5	punct	_
9	is	be	VBZ	pb=be.01	0	root	_
10	now	now	RB	_	9	advmod	9:AM-TMP
11	in	in	IN	_	9	prep	9:A2=PRD
12	a	a	DT	_	16	det	_
13	Phase	phase	NNP	p2=NN	16	nn	_
14	2	0	CD	_	13	num	_
15	clinical	clinical	JJ	_	16	amod	_
16	study	study	NN	_	11	pobj	_
17	in	in	IN	_	16	prep	_
18	patients	patient	NNS	_	17	pobj	_
19	with	with	IN	_	18	prep	_
20	diabetic	diabetic	JJ	_	21	amod	_
21	nephropathy	nephropathy	NN	p2=NNS	19	pobj	_
22	and	and	CC	_	9	cc	_
23	has	have	VBZ	_	24	aux	_
24	shown	show	VBN	pb=show.01	9	conj	_
25	promise	promise	NN	_	24	dobj	24:A1=PPT
26	in	in	IN	_	24	prep	24:AM-LOC
27	several	several	JJ	_	30	amod	_
28	other	other	JJ	_	30	amod	_
29	disease	disease	NN	_	30	nn	_
30	models	model	NNS	_	26	pobj	_
31	,	,	,	_	30	punct	_
32	including	include	VBG	_	30	prep	_
33	atherosclerosis	atherosclerosis	NN	p2=NNS	32	pobj	_
34	,	,	,	_	33	punct	_
35	lung	lung	NN	_	33	conj	_
36	and	and	CC	_	35	cc	_
37	liver	liver	NN	_	35	conj	_
38	fibrosis	fibrosis	NN	p2=NNS	35	conj	_
39	,	,	,	_	38	punct	_
40	osteoporosis	osteoporosis	NN	_	38	conj	_
41	,	,	,	_	40	punct	_
42	and	and	CC	_	40	cc	_
43	in	in	IN	_	32	prep	_
44	models	model	NNS	_	43	pobj	_
45	of	of	IN	_	44	prep	_
46	angiogenesis	angiogenesis	NN	p2=NNS	45	pobj	_
47	.	.	.	_	9	punct	_

1	Genkyotex	genkyotex	NNP	p2=NN	3	nsubjpass	17:A0=PAG;3:A1=PPT
2	was	be	VBD	_	3	auxpass	_
3	founded	found	VBN	pb=found.01	0	root	_
4	in	in	IN	_	3	prep	3:AM-TMP
5	2006	0	CD	_	4	pobj	_
6	by	by	IN	_	3	agent	3:A0=PAG
7	scientists	scientist	NNS	_	6	pobj	_
8	from	from	IN	_	7	prep	_
9	Switzerland	switzerland	NNP	_	8	pobj	_
10	,	,	,	_	9	punct	_
11	the	the	DT	_	12	det	_
12	USA	usa	NNP	_	9	conj	_
13	and	and	CC	_	12	cc	_
14	Japan	japan	NNP	_	12	conj	_
15	,	,	,	_	3	punct	_
16	with	with	IN	_	3	prep	3:AM-MNR
17	backing	back	VBG	p2=NN|pb=back.01	16	pcomp	_
18	from	from	IN	_	17	prep	17:A1=PPT
19	Geneva	geneva	NNP	_	21	nn	_
20	incubator	incubator	NN	p2=NNP	21	nn	_
21	Eclosion	eclosion	NN	p2=NNP	18	pobj	_
22	.	.	.	_	3	punct	_

1	Since	since	IN	_	28	prep	28:AM-TMP
2	2011	0	CD	_	1	pobj	_
3	,	,	,	_	28	punct	_
4	expansion	expansion	NN	_	28	nsubj	28:A0
5	of	of	IN	_	4	prep	_
6	the	the	DT	_	8	det	_
7	investor	investor	NN	_	8	nn	_
8	base	base	NN	_	5	pobj	10:A1=PPT
9	,	,	,	_	8	punct	_
10	led	lead	VBN	pb=lead.02	8	partmod	_
11	by	by	IN	_	10	agent	10:A0=PAG
12	Edmond	edmond	NNP	_	16	nn	_
13	de	de	FW	p2=NNP	16	nn	_
14	Rothschild	rothschild	NNP	_	16	nn	_
15	Investment	investment	NNP	_	16	nn	_
16	Partners	partner	NNPS	p2=NNP	11	pobj	_
17	,	,	,	_	16	punct	_
18	with	with	IN	_	16	prep	_
19	Vesalius	vesalius	NNP	p2=NNPS	20	nn	_
20	BioCapital	biocapital	NNP	_	18	pobj	_
21	and	and	CC	_	20	cc	_
22	MP	mp	NNP	_	25	nn	_
23	Healthcare	healthcare	NNP	_	25	nn	_
24	Venture	venture	NNP	_	25	nn	_
25	Management	management	NNP	_	20	conj	_
26	,	,	,	_	28	punct	_
27	has	have	VBZ	_	28	aux	_
28	provided	provided	VBN	pb=provide.01	0	root	_
29	significant	significant	JJ	_	30	amod	_
30	investment	investment	NN	_	28	dobj	28:A1
31	to	to	IN	p2=TO	28	prep	28:A2
32	Genkyotex	genkyotex	NNP	_	31	pobj	_
33	.	.	.	_	28	punct	_

1	Further	far	RB	p2=JJ	2	amod	_
2	information	information	NN	_	5	nsubjpass	5:A1=PPT
3	can	can	MD	_	5	aux	5:AM-MOD
4	be	be	VB	_	5	auxpass	_
5	found	find	VBN	pb=find.01	0	root	_
6	at	at	IN	_	5	prep	5:AM-LOC
7	:	:	:	_	6	punct	_
8	www.genkyotex.com	#url#	ADD	_	6	pobj	_
9	.	.	.	_	5	punct	_

1	Genkyotex	genkyotex	NNP	p2=NN	12	nsubj	12:A0=PAG
2	,	,	,	_	1	punct	_
3	the	the	DT	_	5	det	_
4	leading	lead	VBG	p2=JJ|pb=lead.01	5	amod	_
5	developer	developer	NN	_	1	appos	4:A0=PAG
6	of	of	IN	_	5	prep	_
7	selective	selective	JJ	_	10	amod	_
8	NOX	nox	NNP	p2=NN	9	nn	_
9	enzyme	enzyme	NNP	p2=NN	10	nn	_
10	inhibitors	inhibitor	NNS	p2=NNP	6	pobj	_
11	,	,	,	_	12	punct	_
12	appointed	appoint	VBD	p2=VBN|pb=appoint.01	0	root	_
13	Dr.	dr.	NNP	_	15	nn	_
14	Jeanette	jeanette	NNP	_	15	nn	_
15	Wood	wood	NNP	_	12	dobj	12:A1=PPT
16	as	as	IN	_	12	prep	12:A2=PRD
17	Chief	chief	NNP	_	19	nn	_
18	Scientific	scientific	NNP	_	19	nn	_
19	Officer	officer	NNP	_	16	pobj	_
20	and	and	CC	_	19	cc	_
21	Dr.	dr.	NNP	_	23	nn	_
22	Joseph	joseph	NNP	_	23	nn	_
23	McCracken	mccracken	NNP	_	19	conj	_
24	to	to	IN	_	12	prep	_
25	the	the	DT	_	26	det	_
26	Board	board	NNP	_	24	pobj	_
27	of	of	IN	_	26	prep	_
28	Directors	director	NNPS	p2=NNS	27	pobj	_
29	.	.	.	_	12	punct	_

